Jean-Michel Lefrancois

This inventor holds 19 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 6 EPO patents. Top assignees: Galapagos Nv, Abbvie S.a.r.l., Galapagos Sas. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Michel Lefrancois. Retrieved from https://idiyas.com/inventor/jean-michel-lefrancois

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 3)

% Patents Active = 78.9

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 1)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Livry Gargan, FR (1999 - 2014)
Le Raincy, FR (2005 - 2020)

Company Filing History:

Hoechst Aktiengesellschaft

7. 4 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2020-05-12),

2. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2019-04-16),

3. 10130622 - Compounds for treatment of cystic fibrosis (2018-11-20),

4. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use (2018-02-13),

5. 9796711 - [object Object] (2017-10-24),

6. 8765766 - Pyrimidine derivatives which are antagonists of the vitronectin receptor (2014-07-01),

7. 8133896 - Pyrimidine derivatives which are antagonist of the vitronectin receptor (2012-03-13),

8. 7846932 - Methods for the use of pyrimidine derivatives which are antagonists of vitronectin receptor (2010-12-07),

9. 7825119 - Pyrimidine derivatives which are antagonists of vitronectin receptor (2010-11-02),

10. 7763621 - Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same (2010-07-27),

11. 7582640 - Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same (2009-09-01),

12. 6867208 - Vitronectin receptor antagonists, their preparation and their use (2005-03-15),

13. 6838453 - Antagonist derivatives of the vitronectin receptor (2005-01-04),

14. 6482821 - Vitronectin receptor antagonists, their preparation and their use (2002-11-19),

15. 6387895 - Vitronectin receptor antagonists, their preparation and their use (2002-05-14),

Title: Jean-Michel Lefrancois: Pioneering Inventor from Livry Gargan

Introduction: Jean-Michel Lefrancois is a renowned inventor hailing from Livry Gargan, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean-Michel Lefrancois holds several patents in the areas of renewable energy, sustainable transportation, and smart city solutions, showcasing his commitment to creating a more environmentally friendly world.

Career Highlights: With a career spanning over two decades, Jean-Michel Lefrancois has worked with leading tech companies to develop cutting-edge technologies that have revolutionized various industries. His innovative spirit and dedication to excellence have earned him recognition as a thought leader in the field.

Collaborations: Throughout his career, Jean-Michel Lefrancois has collaborated with top researchers, engineers, and designers to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of numerous projects.

Conclusion: Jean-Michel Lefrancois continues to inspire the next generation of inventors with his passion for innovation and his relentless pursuit of technological advancement. His impact on the world of inventions is truly remarkable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.